查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1668169

动物干细胞治疗市场 - 全球产业规模、份额、趋势、机会和预测，按类型、应用、地区和竞争细分，2020-2030 年预测

Animal Stem Cell Therapy Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type, By Application, By Region, & Competition, 2020-2030F
出版日期: | 出版商: TechSci Research | 英文 180 Pages | 商品交期: 2-3个工作天内

价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

简介目录

2024 年全球动物干细胞治疗市场价值为 2.3809 亿美元，预计在预测期内将经历显着增长，到 2030 年的年复合成长率(CAGR) 为 6.01%。该行业因其具有改善宠物、牲畜和野生动物等各种动物的健康和福祉的潜力而受到了广泛关注。

市场概况
预测期 2026-2030
2024 年市场规模 2.3809 亿美元
2030 年市场规模 3.3871亿美元
2025-2030 年复合年增长率 6.01％
成长最快的领域 狗干细胞疗法
最大的市场 北美洲

主要市场驱动因素

宠物拥有量成长和动物保健支出增加

主要市场挑战

安全性和有效性问题

目录

第 1 章：产品概述

第 2 章：研究方法

第 3 章：执行摘要

第 4 章：顾客之声

第五章：全球动物干细胞治疗市场展望

  • 市场规模和预测
    • 按价值
  • 市场占有率和预测
    • 依类型（狗干细胞疗法、马干细胞疗法）
    • 依应用（兽医院、研究机构）
    • 按地区
    • 按公司分类（2024）
  • 产品市场图
    • 按类型
    • 按应用
    • 按地区

第 6 章：北美动物干细胞治疗市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • 北美：国家分析
    • 加拿大
    • 墨西哥

第 7 章：欧洲动物干细胞治疗市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • 欧洲：国家分析
    • 英国
    • 法国
    • 义大利
    • 西班牙

第 8 章：亚太地区动物干细胞治疗市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • 亚太地区：国家分析
    • 日本
    • 印度
    • 澳洲
    • 韩国

第 9 章：南美洲动物干细胞治疗市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • 南美洲：国家分析
    • 阿根廷
    • 哥伦比亚

第 10 章：中东和非洲动物干细胞治疗市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • MEA：国家分析
    • 沙乌地阿拉伯
    • 阿联酋
    • 科威特

第 11 章：市场动态

  • 驱动程式
  • 挑战

第 12 章：市场趋势与发展

  • 近期发展
  • 合併与收购
  • 产品发布

第 13 章：波特五力分析

  • 产业竞争
  • 新进入者的潜力
  • 供应商的力量
  • 顾客的力量
  • 替代产品的威胁

第 14 章：竞争格局

  • Ardent Animal Health
  • Vet Stem Inc
  • Medrego
  • Vetbiologics
  • VETHERAPY
  • Celavie Biosciences
  • Magellan Stem Cells
  • Animal General
  • Animal Cell Therapies, Inc.
  • Cell Therapy Sciences Ltd

第 15 章：策略建议

第16章 调査会社について・免责事项

简介目录
Product Code: 17596

The global Animal Stem Cell Therapy Market was valued at USD 238.09 million in 2024 and is projected to experience significant growth during the forecast period, with a compound annual growth rate (CAGR) of 6.01% through 2030. This market pertains to the use of stem cell-based therapies to treat a variety of medical conditions in animals. The sector has attracted considerable attention due to its potential to enhance the health and well-being of various animals, including pets, livestock, and wildlife.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 238.09 Million
Market Size 2030USD 338.71 Million
CAGR 2025-20306.01%
Fastest Growing SegmentDogs Stem Cell Therapy
Largest MarketNorth America

Key Market Drivers

Growth in Pet Ownership and Increased Animal Healthcare Expenditure

The global Animal Stem Cell Therapy Market is benefiting from robust growth driven by rising pet ownership and increased spending on animal healthcare. Over 50% of the global population is estimated to own pets, with households in the U.S., EU, and China collectively hosting more than 500 million dogs and cats. In the U.S., pet ownership has steadily increased, from 68% of households in 2016 to 70% in 2021, reflecting the growing importance of pets in family life. This trend presents substantial opportunities for industries focused on pet care, nutrition, and related services. Consumers are increasingly prioritizing pet-related products and services, particularly in advanced veterinary treatments such as stem cell therapy.

The pet ownership trend continues to rise, especially in developed regions like North America, Europe, and parts of Asia-Pacific. Younger generations, including Millennials and Gen Z, are particularly likely to adopt pets as companions. A survey indicates that 45% of Gen Z and 40% of Millennials consider their pets the most important part of their lives, underlining a significant emotional and financial investment in pet care. In contrast, only 29% of older generations share this perspective, highlighting a generational shift in consumer behavior and spending patterns within the pet care industry.

Additionally, pets are increasingly seen as sources of emotional support, contributing to a growing demand for quality healthcare services. In the Asia-Pacific region, particularly in China, the pet humanization trend is on the rise, with 55% of pet owners considering their pets as children, and 28% regarding them as family members.

Key Market Challenges

Safety and Efficacy Concerns

Ensuring the safety and efficacy of stem cell therapies for animals remains a critical challenge. Although these therapies show significant promise, further research and clinical trials are necessary to establish their long-term safety and effectiveness for various medical conditions across different animal species.

Key Market Players

  • Ardent Animal Health
  • Vet Stem Inc
  • Medrego
  • Vetbiologics
  • VETHERAPY
  • Celavie Biosciences
  • Magellan Stem Cells
  • Animal General
  • Animal Cell Therapies, Inc.
  • Cell Therapy Sciences Ltd

Report Scope

This report provides a comprehensive analysis of the global Animal Stem Cell Therapy Market, segmented as follows, with a detailed overview of industry trends:

By Type:

  • Dogs Stem Cell Therapy
  • Horses Stem Cell Therapy

By Application:

  • Veterinary Hospitals
  • Research Organizations

By Region:

  • North America
  • United States
  • Canada
  • Mexico
  • Europe
  • Germany
  • United Kingdom
  • France
  • Italy
  • Spain
  • Asia-Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • South America
  • Brazil
  • Argentina
  • Colombia
  • Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Competitive Landscape and Company Profiles

The report provides an in-depth analysis of leading companies operating within the global Animal Stem Cell Therapy Market.

Available Customizations

TechSci Research offers customizations tailored to a company's specific needs.

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Animal Stem Cell Therapy Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Type (Dogs Stem Cell Therapy, Horses Stem Cell Therapy)
    • 5.2.2. By Application (Veterinary Hospitals, Research Organizations)
    • 5.2.3. By Region
    • 5.2.4. By Company (2024)
  • 5.3. Product Market Map
    • 5.3.1. By Type
    • 5.3.2. By Application
    • 5.3.3. By Region

6. North America Animal Stem Cell Therapy Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type (Dogs Stem Cell Therapy, Horses Stem Cell Therapy)
    • 6.2.2. By Application (Veterinary Hospitals, Research Organizations)
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Animal Stem Cell Therapy Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Type
        • 6.3.1.2.2. By Application
    • 6.3.2. Canada Animal Stem Cell Therapy Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Type
        • 6.3.2.2.2. By Application
    • 6.3.3. Mexico Animal Stem Cell Therapy Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Type
        • 6.3.3.2.2. By Application

7. Europe Animal Stem Cell Therapy Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type (Dogs Stem Cell Therapy, Horses Stem Cell Therapy)
    • 7.2.2. By Application (Veterinary Hospitals, Research Organizations)
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Animal Stem Cell Therapy Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Type
        • 7.3.1.2.2. By Application
    • 7.3.2. United Kingdom Animal Stem Cell Therapy Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Type
        • 7.3.2.2.2. By Application
    • 7.3.3. France Animal Stem Cell Therapy Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Type
        • 7.3.3.2.2. By Application
    • 7.3.4. Italy Animal Stem Cell Therapy Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Type
        • 7.3.4.2.2. By Application
    • 7.3.5. Spain Animal Stem Cell Therapy Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Type
        • 7.3.5.2.2. By Application

8. Asia-Pacific Animal Stem Cell Therapy Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type (Dogs Stem Cell Therapy, Horses Stem Cell Therapy)
    • 8.2.2. By Application (Veterinary Hospitals, Research Organizations)
    • 8.2.3. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Animal Stem Cell Therapy Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Type
        • 8.3.1.2.2. By Application
    • 8.3.2. Japan Animal Stem Cell Therapy Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Type
        • 8.3.2.2.2. By Application
    • 8.3.3. India Animal Stem Cell Therapy Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Type
        • 8.3.3.2.2. By Application
    • 8.3.4. Australia Animal Stem Cell Therapy Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Type
        • 8.3.4.2.2. By Application
    • 8.3.5. South Korea Animal Stem Cell Therapy Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Type
        • 8.3.5.2.2. By Application

9. South America Animal Stem Cell Therapy Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type (Dogs Stem Cell Therapy, Horses Stem Cell Therapy)
    • 9.2.2. By Application (Veterinary Hospitals, Research Organizations)
    • 9.2.3. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Animal Stem Cell Therapy Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Type
        • 9.3.1.2.2. By Application
    • 9.3.2. Argentina Animal Stem Cell Therapy Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Type
        • 9.3.2.2.2. By Application
    • 9.3.3. Colombia Animal Stem Cell Therapy Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Type
        • 9.3.3.2.2. By Application

10. Middle East and Africa Animal Stem Cell Therapy Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Type (Dogs Stem Cell Therapy, Horses Stem Cell Therapy)
    • 10.2.2. By Application (Veterinary Hospitals, Research Organizations)
    • 10.2.3. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Animal Stem Cell Therapy Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Type
        • 10.3.1.2.2. By Application
    • 10.3.2. Saudi Arabia Animal Stem Cell Therapy Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Type
        • 10.3.2.2.2. By Application
    • 10.3.3. UAE Animal Stem Cell Therapy Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Type
        • 10.3.3.2.2. By Application
    • 10.3.4. Kuwait Animal Stem Cell Therapy Market Outlook
      • 10.3.4.1. Market Size & Forecast
        • 10.3.4.1.1. By Value
      • 10.3.4.2. Market Share & Forecast
        • 10.3.4.2.1. By Type
        • 10.3.4.2.2. By Application

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Development
  • 12.2. Mergers & Acquisitions
  • 12.3. Product Launches

13. Porter's Five Forces Analysis

  • 13.1. Competition in the Industry
  • 13.2. Potential of New Entrants
  • 13.3. Power of Suppliers
  • 13.4. Power of Customers
  • 13.5. Threat of Substitute Products

14. Competitive Landscape

  • 14.1. Ardent Animal Health
    • 14.1.1. Business Overview
    • 14.1.2. Product & Service Offerings
    • 14.1.3. Recent Developments
    • 14.1.4. Financials (If Listed)
    • 14.1.5. Key Personnel
    • 14.1.6. SWOT Analysis
  • 14.2. Vet Stem Inc
  • 14.3. Medrego
  • 14.4. Vetbiologics
  • 14.5. VETHERAPY
  • 14.6. Celavie Biosciences
  • 14.7. Magellan Stem Cells
  • 14.8. Animal General
  • 14.9. Animal Cell Therapies, Inc.
  • 14.10. Cell Therapy Sciences Ltd

15. Strategic Recommendations

16. About Us & Disclaimer